HARVARD MANAGEMENT CO INC - Q4 2022 holdings

$807 Million is the total value of HARVARD MANAGEMENT CO INC's 46 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 6.4% .

 Value Shares↓ Weighting
GOOGL  Alphabet Inccap stk cl a$212,770,174
-7.8%
2,411,5400.0%26.38%
-8.1%
SGMS  Light & Wonder Inc$156,964,261
+36.7%
2,678,5710.0%19.46%
+36.2%
FB  Meta Platforms Inccl a$136,696,131
-11.3%
1,135,9160.0%16.95%
-11.6%
BuyGrab Holdings Limitedclass a ord$41,977,472
+71.6%
13,036,482
+40.2%
5.20%
+71.0%
ABCL  Abcellera Biologics Inc$41,584,612
+2.4%
4,105,0950.0%5.16%
+2.1%
PCTTW  Purecycle Technologies Inc*w exp 03/17/202$16,887,629
+595.3%
714,2850.0%2.09%
+593.4%
RVMD  Revolution Medicines Inc$15,968,499
+20.8%
670,3820.0%1.98%
+20.4%
RXRX  Recursion Pharmaceuticals Incl a$11,636,348
-27.5%
1,509,2540.0%1.44%
-27.8%
ASML  ASML Holding N V$11,029,630
+31.6%
20,1860.0%1.37%
+31.1%
PLRX  Pliant Therapeutics Inc$10,870,786
-7.5%
562,3790.0%1.35%
-7.8%
 Meli Kaszek Pioneer Corpclass a ord$9,970,000
+1.0%
1,000,0000.0%1.24%
+0.7%
NVDA  Nvidia Corporation$9,699,020
+20.4%
66,3680.0%1.20%
+20.0%
QRVO  Qorvo Inc$9,487,198
+14.1%
104,6690.0%1.18%
+13.7%
SellEQRX Inc$9,479,283
-63.6%
3,853,367
-26.8%
1.18%
-63.7%
ADI  Analog Devices Inc$8,950,789
+17.7%
54,5680.0%1.11%
+17.3%
AMAT  Applied Matls Inc$8,612,579
+18.9%
88,4430.0%1.07%
+18.4%
RLAY  Relay Therapeutics Inc$8,084,393
-33.2%
541,1240.0%1.00%
-33.5%
LRCX  Lam Research Corp$8,040,759
+14.8%
19,1310.0%1.00%
+14.5%
TSM  Taiwan Semiconductor Mfg Ltdsponsored ads$7,992,330
+8.7%
107,2940.0%0.99%
+8.3%
AMD  Advanced Micro Devices Inc$7,263,113
+2.2%
112,1370.0%0.90%
+1.8%
TXG  10X Genomics Inc$6,783,051
+28.0%
186,1430.0%0.84%
+27.4%
INTC  Intel Corp$5,490,885
+2.6%
207,7520.0%0.68%
+2.3%
MU  Micron Technology Inc$5,373,950
-0.2%
107,5220.0%0.67%
-0.6%
 Tango Therapeutics Inc$5,135,791
+100.3%
708,3850.0%0.64%
+99.7%
 Rocket Lab Usa Inc$3,770,000
-7.4%
1,000,0000.0%0.47%
-7.7%
 Vigil Neuroscience Inc$3,618,250
+37.4%
289,4600.0%0.45%
+36.9%
NRIX  Nurix Therapeutics Inc$3,456,087
-15.7%
314,7620.0%0.43%
-16.1%
KNTE  Kinnate Biopharma Inc$3,037,806
-49.0%
498,0010.0%0.38%
-49.1%
FULC  Fulcrum Therapeutics Inc$2,989,998
-10.0%
410,7140.0%0.37%
-10.2%
CFLT  Confluent Inc$2,899,718
-6.4%
130,3830.0%0.36%
-7.0%
PCT  Purecycle Technologies Inc$2,057,141
-89.8%
2,498,1700.0%0.26%
-89.8%
GBIO  Generation Bio Co$2,005,691
-26.0%
510,3540.0%0.25%
-26.1%
 Nauticus Robotics Inc.$1,870,000
+3.6%
500,0000.0%0.23%
+3.1%
PACB  Pacific Biosciences Calif Inc$1,874,398
+40.9%
229,1440.0%0.23%
+40.6%
SANA  Sana Biotechnology Inc$1,851,559
-34.2%
468,7490.0%0.23%
-34.3%
PRAX  Praxis Precision Medicines Inc$1,852,870
+4.9%
778,5170.0%0.23%
+4.5%
AFRM  Affirm Hldgs Inc$1,678,325
-48.5%
173,5600.0%0.21%
-48.6%
 Tenaya Therapeutics Inc$1,353,273
-30.7%
673,2700.0%0.17%
-30.9%
DYN  Dyne Therapeutics Inc$1,243,051
-8.7%
107,2520.0%0.15%
-8.9%
 Xilio Therapeutics Inc$1,119,199
-7.6%
416,0590.0%0.14%
-7.9%
MCRB  Seres Therapeutics Inc$738,343
-12.7%
131,8470.0%0.09%
-12.4%
 Pardes Biosciences Inc$676,000
-8.6%
400,0000.0%0.08%
-8.7%
DBTX  Decibel Therapeutics Inc$674,036
-40.8%
328,7980.0%0.08%
-40.8%
NewDisc Medicine Inc$497,25025,000
+100.0%
0.06%
 Surrozen Inc$481,145
-71.2%
826,8520.0%0.06%
-71.2%
MGTA  Magenta Therapeutics Inc$131,381
-72.0%
332,6100.0%0.02%
-72.4%
GMTX ExitGemini Therapeutics Inc$0-250,000
-100.0%
-0.05%
LAUR ExitLaureate Education Inc$0-101,804
-100.0%
-0.13%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (806624206.0 != 806624204.0)

Export HARVARD MANAGEMENT CO INC's holdings